No evidence for ischemic preconditioning during repeated vessel occlusion in coronary angioplasty

International Journal of Cardiology

Volumn 55, Issue 3, 1996, Pages 227-237

  Ylitalo, Kari ^a   Airaksinen, Juhani ^a   Ikäheimo, Markku ^a   Ruskoaho, Heikki ^a   Peuhkurinen, Keijo ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Angioplasty; Ischemia; Metabolism; Preconditioning

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; LACTIC ACID;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL;

EID: 0030220245     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02710-6     Document Type: Article

References (45)

1. [1] Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
2. [2] Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990; 82: 609-619.
3. [3] Cave AC, Collis CS, Downey JM, Hearse DJ. Improved functional recovery by ischemic preconditioning is not mediated by adenosine in the globally ischemic isolated rat heart. Cardiovasc Res 1993: 27: 663-668.
4. [4] Vegh A, Komori S, Szekeres L, Parratt JR. Anti-arrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 1992; 26: 487-495.
5. [5] Ovize M, Kloner RA, Hale SL, Przyklenk K. Coronary cyclic flow variations 'precondition' ischemic myocardium. Circulation 1992; 85: 779-789.
6. [6] Shizukuda Y, Mallet RT, Lee S-C, Downey HF. Hypoxic preconditioning of ischemic canine myocardium. Cardiovasc Res 1992; 26: 534-542.
7. [7] Gulker H, Kramer B, Stephen K, Meesman W. Changes in ventricular fibrillation threshold during regional short-term coronary occlusion and release. Basic Res Cardiol 1977; 72: 547-562.
8. [8] Miyazaki T, Zipes DP. Protection against autonomic denervation following acute myocardial infarction by preconditioning ischemia. Circ Res 1989; 64: 437-448.
9. [9] Muller DWM, Topol EJ, Califf RM, et al. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Am Heart J 1990; 119: 224-231.
10. [10] Yoshikawa T, Inoue S, Abe S, et al. Acute myocardial infarction without warning: clinical characteristics and significance of pre-infarction angina. Cardiology 1993; 82: 42-47.
11. [11] Hirai T, Fujita M, Yoshida N, Yamanishi K, Inoko M, Miwa K. Importance of ischemic preconditioning and collateral circulation for left ventricular functional recovery in patients with successful intracoronary thrombolysis for acute myocardial infarction. Am Heart J 1993; 126: 827-831.
12. [12] Kloner RA, Shook T, Przyklenk K. et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995; 91: 37-47.
13. [13] Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 1995; 91: 291-297.
14. [14] Anreotti F, Pasceri V, Hackett D et al. Pre-infarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996, 334: 7-12.
15. [15] Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993; 342: 276-277.
16. [16] Alkhulaifi AM, Yellon DM, Pugsley WB. Preconditioning the human heart during aorto-coronary bypass surgery. Eur J Cardiothorac Surg 1994; 8: 270-276.
17. [17] Hill JA, Feldman RL, MacDonald RG, Pepine CJ. Coronary artery collateral visualisation during acute coronary occlusion. Am J Cardiol 1985; 55: 1216-1218.
18. [18] Serruys PW, Wijns W, van den Brand M, et al. Left ventricular performance, regional blood flow, wall motion and lactate metabolism during transluminal angioplasty. Circulation 1984; 70: 25-36.
19. [19] Zalewski A, Goldberg S, Dervan JP, Slysh S, Maroko PR. Myocardial protection during transient coronary artery occlusion in man: beneficial effects of regional β-adrenergic blockade. Circulation 1986; 73: 734-739.
20. [20] Feldman RL, MacDonald RG, Hill JA, Limacher MC, Conti R, Pepine CJ. Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion. Circulation 1986; 73: 727-733.
21. [21] Griffin B, Timmis AD, Crick CP, Sowton E. The evolution of myocardial ischemia during percutaneous transluminal coronary angioplasty. Eur Heart J 1987; 8: 347-353.
22. [22] Huizer T, de Jong JW, Nelson JA, et al. Urate production by human heart. J Mol Cell Cardiol 1989; 21: 691-695.
23. [23] Perry RA, Seth A, Hunt A, et al. Balloon occlusion during coronary angioplasty as a model of myocardial ischemia: reproducibility of sequential inflations. Eur Heart J 1989; 10: 791-800.
24. [24] Serruys PW, Suryapranata H, Piscione F, et al. Myocardial release of hypoxanthine and lactate during percutaneous transluminal coronary angioplasty. Am J Cardiol 1989; 63: 45-51.
25. [25] Oldroyd KG, Paterson JR, Rumley AG, et al. Coronary venous lipid peroxide concentrations after coronary angioplasty: correlation with biochemical and electrocardiographic evidence of myocardial ischemia. Br Heart J 1992; 68: 43-47.
26. [26] Uusimaa PA, Ikäheimo MJ, Ruskoaho H, et al. Release of atrial natriuretic peptide in relation to metabolic changes during myocardial ischemia induced by coronary angioplasty. Eur Heart J 1993; 14: 682-686.
27. [27] Deutsch E, Berger M, Kussmaul WG, Hirshfeld Jr JW, Herrman HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic and metabolic features. Circulation 1990; 82: 2044-2051.
28. [28] Cribier A, Korsatz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 1992; 20: 578-586.
29. [29] Koning R, Cribier A, Korsatz L, et al. Progressive decrease in myocardial ischemia assessed by intracoronary electrocardiogram during successive and prolonged coronary occlusions in angioplasty. Am Heart J 1993; 125: 56-61.
30. [30] Tomai F, Crea F, Gaspardone A, et al. Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol 1993; 22: 1892-1896.
31. + channel blocker, Circulation 1994; 90: 700-705.
32. [32] Borg G, Holmgren A, Lindblad I. Quantitative evaluation of chest pain. Acta Med Scand 1981; 644: 43-45.
33. [33] Ruskoaho H, Taskinen T, Pesonen A, et al. Atrial natriuretic peptide in plasma, atria, ventricles and hypothalamus of Long-Evans and vasopressin-deficient Brattleboro rats. Endocrinology 1989; 124: 2595-2603.
34. [34] Peuhkurinen KJ, Huikuri HV, Ruskoaho H, Takkunen JT. Blood pressure, plasma atrial natriuretic peptide and catecholamines during rapid ventricular pacing and effects of β-adrenergic blockade in coronary artery disease. Am J Cardiol 1992; 69: 35-39.
35. [35] Airaksinen KEJ, Ikäheimo MJ, Huikuri HV, Linnaluoto MK, et al. Responses of heart rate variability to coronary occlusion during coronary angioplasty. Am J Cardiol 1993; 72: 1026-1030.
36. [36] Yellon DM, Downey 3M, Pugsley WB. Ischaemic preconditioning. Lancet 1993; 341: 1325-1326.
37. [37] Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 h following brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264-1272.
38. [38] Yellon DM, Baxter GF. A 'second window of protection' or delayed preconditioning phenomenon: future horizons for myocardial protection? J Moll Cell Cardiol 1995; 27, 1023-1034.
39. [39] Ikäheimo MJ, Ruskoaho HJ, Airaksinen KEJ, et al. Plasma levels of atrial natriuretic peptide during myocardial ischemia induced by percutaneous transluminal coronary angiopiasty or dynamic exercise. Am Heart J 1989; 117: 837-841.
40. [40] Schömig A, Ness G, Mayer E, et al. Sympathetic activity in patients with acute myocardial infarction before and after intracoronary thrombolytic therapy (abstract) Eur Heart J 1984; 5 (Suppl 1): 39.
41. [41] Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled-coronary artery occlusion in human subjects: a prospective study. Circulation 1986; 74: 469-476.
42. [42] Mizuno K, Horiuchi K, Matui H, et al. Role of coronary collateral vessels during transient coronary occlusion during angioplasty assessed by hemodynamic, electrocardiographic and metabolic changes. J Am Coll Cardiol 1988; 12: 624-628.
43. [43] Heibig J, Bolli R, Harris S. Initial coronary occlusion improves tolerance to subsequent prolonged balloon inflations. Catheter Cardiovasc Diagn 1989; 16: 99-102.
44. [44] Mohri M, Tomoike H, Noma M, Inoue T, Hisano K, Nakamura M. Duration of ischemia is vital for collateral development: repeated brief coronary artery occlusions in conscious dogs. Circ Res 1989; 64: 287-296.
45. [45] Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993; 27: 542-550.